Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The cholesterol pathway: impact on immunity and cancer

Trends in Immunology(2021)10.1016/j.it.2021.11.007Source: DataRank Database

The cholesterol pathway: impact on immunity and cancer is a research paper published in Trends in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 214 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access214 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 9.45)OA: greenTopics (41)Linked Datasets (22)DataCite Reuse (22)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Pankaj K. Singh ORCID,Kamiya Mehla ORCID,Ryan J. King ORCID

Live enrichment

PubMed:34942082 PMC:PMC8812650 OpenAlex:https://openalex.org/W4200199890

National Institutes of Health

Grant: R01CA163649

National Institutes of Health

Grant: R01CA210439

National Institutes of Health

Grant: R01 CA216853

National Institutes of Health

Grant: P01 CA2117798

NCI NIH HHS

Grant: P01 CA217798

National Institutes of Health

Grant: 5R01CA210439-05

Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer

National Institutes of Health

Grant: 5P01CA217798-04

Pancreatic Cancer Metastasis

National Institutes of Health

Grant: 3R01CA216853-03S1

Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer

National Cancer Institute

FWCI

9.45

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8812650

publisherhttps://api.elsevier.com/content/article/PII:S147149062100243X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S147149062100243X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.it.2021.11.007

Fields of Study

Cancer, Lipids, and MetabolismCholesterol and Lipid MetabolismFerroptosis and cancer prognosis0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsAnti-Inflammatory AgentsAtherosclerosisCholesterolHumansImmunity, InnateMammalsNeoplasms

MeSH Terms

AnimalsAnti-Inflammatory AgentsCholesterolHumansImmunity, InnateMammalsNeoplasmsAtherosclerosis

Keywords

ImmunityCancerImmunologyCholesterolMedicineBiologyImmune systemInternal medicineImmuneLXRstatinsOxysterolMammalsNeoplasmsAnti-Inflammatory AgentsAnimalsHumansAtherosclerosisImmunity, Innate

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Multiplex immunohistochemistry defines two cholesterol metabolism patterns predicting immunotherapeutic outcomes in gastric cancer

10.6084/m9.figshare.24770396.v1figshare

Additional file 1 of Multiplex immunohistochemistry defines two cholesterol metabolism patterns predicting immunotherapeutic outcomes in gastric cancer

10.6084/m9.figshare.24770396figshare

Additional file 2 of Multiplex immunohistochemistry defines two cholesterol metabolism patterns predicting immunotherapeutic outcomes in gastric cancer

10.6084/m9.figshare.24770645.v1figshare

Additional file 2 of Multiplex immunohistochemistry defines two cholesterol metabolism patterns predicting immunotherapeutic outcomes in gastric cancer

10.6084/m9.figshare.24770645figshare

Additional file 1 of Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice

10.6084/m9.figshare.25530174.v1figshare

Additional file 1 of Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice

10.6084/m9.figshare.25530174figshare

Additional file 1 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.25770374.v1figshare

Additional file 1 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.25770374figshare

Additional file 2 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.25770510.v1figshare

Additional file 2 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.25770510figshare

Additional file 3 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.26717541.v1figshare

Additional file 3 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.26717541figshare

Additional file 4 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.26717544.v1figshare

Additional file 4 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.26717544figshare

Additional file 5 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.26717547.v1figshare

Additional file 5 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.26717547figshare

Additional file 6 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.26717550.v1figshare

Additional file 6 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.26717550figshare

Additional file 7 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.26717553.v1figshare

Additional file 7 of Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells

10.6084/m9.figshare.26717553figshare

The cholesterol pathway: impact on immunity and cancer

FAIR Checklist

Authors (3)

Funding (9 grants)

Impact

Open Access

Topics

Linked Datasets (22)

Annotations (Europe PMC)